nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.512	1	CpDpCtD
Atropine—CYP1A2—type 2 diabetes mellitus	0.228	1	CbGaD
Atropine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0218	0.329	CbGbCtD
Atropine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0172	0.259	CbGbCtD
Atropine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0162	0.245	CbGbCtD
Atropine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0111	0.167	CbGbCtD
Atropine—Dolasetron—CYP3A4—type 2 diabetes mellitus	0.000358	0.364	CrCbGaD
Atropine—Granisetron—CYP3A4—type 2 diabetes mellitus	0.000327	0.333	CrCbGaD
Atropine—Cocaine—CYP3A4—type 2 diabetes mellitus	0.000156	0.158	CrCbGaD
Atropine—Ipratropium bromide—CYP3A4—type 2 diabetes mellitus	0.000142	0.145	CrCbGaD
Atropine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000106	0.000795	CcSEcCtD
Atropine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000106	0.000795	CcSEcCtD
Atropine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000106	0.000794	CcSEcCtD
Atropine—Erythema—Losartan—type 2 diabetes mellitus	0.000106	0.000794	CcSEcCtD
Atropine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000105	0.000792	CcSEcCtD
Atropine—Oedema—Orlistat—type 2 diabetes mellitus	0.000105	0.000792	CcSEcCtD
Atropine—Headache—Glipizide—type 2 diabetes mellitus	0.000105	0.000791	CcSEcCtD
Atropine—Palpitations—Metformin—type 2 diabetes mellitus	0.000105	0.00079	CcSEcCtD
Atropine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000105	0.000789	CcSEcCtD
Atropine—Shock—Valsartan—type 2 diabetes mellitus	0.000105	0.000788	CcSEcCtD
Atropine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000105	0.000786	CcSEcCtD
Atropine—Tension—Losartan—type 2 diabetes mellitus	0.000104	0.000779	CcSEcCtD
Atropine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000104	0.000779	CcSEcCtD
Atropine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000103	0.000778	CcSEcCtD
Atropine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000103	0.000778	CcSEcCtD
Atropine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000776	CcSEcCtD
Atropine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000103	0.000775	CcSEcCtD
Atropine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000103	0.000775	CcSEcCtD
Atropine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000103	0.000772	CcSEcCtD
Atropine—Nervousness—Losartan—type 2 diabetes mellitus	0.000103	0.000771	CcSEcCtD
Atropine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000103	0.000771	CcSEcCtD
Atropine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000102	0.000768	CcSEcCtD
Atropine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000102	0.000768	CcSEcCtD
Atropine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000102	0.000766	CcSEcCtD
Atropine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000762	CcSEcCtD
Atropine—Chest pain—Metformin—type 2 diabetes mellitus	0.000101	0.000761	CcSEcCtD
Atropine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000101	0.000758	CcSEcCtD
Atropine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000101	0.000758	CcSEcCtD
Atropine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000101	0.000757	CcSEcCtD
Atropine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.0001	0.000752	CcSEcCtD
Atropine—Nausea—Glipizide—type 2 diabetes mellitus	9.97e-05	0.00075	CcSEcCtD
Atropine—Vomiting—Glimepiride—type 2 diabetes mellitus	9.96e-05	0.000749	CcSEcCtD
Atropine—Hypotension—Valsartan—type 2 diabetes mellitus	9.96e-05	0.000749	CcSEcCtD
Atropine—Vision blurred—Losartan—type 2 diabetes mellitus	9.95e-05	0.000748	CcSEcCtD
Atropine—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.93e-05	0.000747	CcSEcCtD
Atropine—Pain—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.000746	CcSEcCtD
Atropine—Constipation—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.000746	CcSEcCtD
Atropine—Rash—Glimepiride—type 2 diabetes mellitus	9.88e-05	0.000743	CcSEcCtD
Atropine—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.87e-05	0.000742	CcSEcCtD
Atropine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000742	CcSEcCtD
Atropine—Rash—Sitagliptin—type 2 diabetes mellitus	9.85e-05	0.00074	CcSEcCtD
Atropine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.84e-05	0.00074	CcSEcCtD
Atropine—Headache—Glimepiride—type 2 diabetes mellitus	9.81e-05	0.000738	CcSEcCtD
Atropine—Headache—Sitagliptin—type 2 diabetes mellitus	9.78e-05	0.000736	CcSEcCtD
Atropine—Agitation—Losartan—type 2 diabetes mellitus	9.71e-05	0.00073	CcSEcCtD
Atropine—Oedema—Metformin—type 2 diabetes mellitus	9.71e-05	0.00073	CcSEcCtD
Atropine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.67e-05	0.000727	CcSEcCtD
Atropine—Flushing—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000726	CcSEcCtD
Atropine—Angioedema—Losartan—type 2 diabetes mellitus	9.65e-05	0.000726	CcSEcCtD
Atropine—Insomnia—Valsartan—type 2 diabetes mellitus	9.64e-05	0.000725	CcSEcCtD
Atropine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.56e-05	0.000719	CcSEcCtD
Atropine—Chest pain—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000718	CcSEcCtD
Atropine—Shock—Metformin—type 2 diabetes mellitus	9.55e-05	0.000718	CcSEcCtD
Atropine—Insomnia—Orlistat—type 2 diabetes mellitus	9.53e-05	0.000716	CcSEcCtD
Atropine—Anxiety—Irbesartan—type 2 diabetes mellitus	9.52e-05	0.000716	CcSEcCtD
Atropine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.52e-05	0.000716	CcSEcCtD
Atropine—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.5e-05	0.000714	CcSEcCtD
Atropine—Vertigo—Losartan—type 2 diabetes mellitus	9.49e-05	0.000714	CcSEcCtD
Atropine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000713	CcSEcCtD
Atropine—Somnolence—Valsartan—type 2 diabetes mellitus	9.48e-05	0.000712	CcSEcCtD
Atropine—Syncope—Losartan—type 2 diabetes mellitus	9.47e-05	0.000712	CcSEcCtD
Atropine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.38e-05	0.000706	CcSEcCtD
Atropine—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.38e-05	0.000705	CcSEcCtD
Atropine—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.35e-05	0.000703	CcSEcCtD
Atropine—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.000703	CcSEcCtD
Atropine—Palpitations—Losartan—type 2 diabetes mellitus	9.33e-05	0.000702	CcSEcCtD
Atropine—Nausea—Glimepiride—type 2 diabetes mellitus	9.31e-05	0.0007	CcSEcCtD
Atropine—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.29e-05	0.000699	CcSEcCtD
Atropine—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.28e-05	0.000698	CcSEcCtD
Atropine—Nausea—Sitagliptin—type 2 diabetes mellitus	9.28e-05	0.000697	CcSEcCtD
Atropine—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000697	CcSEcCtD
Atropine—Asthenia—Glyburide—type 2 diabetes mellitus	9.27e-05	0.000697	CcSEcCtD
Atropine—Urticaria—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000693	CcSEcCtD
Atropine—Fatigue—Valsartan—type 2 diabetes mellitus	9.19e-05	0.000691	CcSEcCtD
Atropine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.17e-05	0.00069	CcSEcCtD
Atropine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.17e-05	0.00069	CcSEcCtD
Atropine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000689	CcSEcCtD
Atropine—Oedema—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000689	CcSEcCtD
Atropine—Pruritus—Glyburide—type 2 diabetes mellitus	9.14e-05	0.000687	CcSEcCtD
Atropine—Mental disorder—Ramipril—type 2 diabetes mellitus	9.12e-05	0.000685	CcSEcCtD
Atropine—Constipation—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000685	CcSEcCtD
Atropine—Fatigue—Orlistat—type 2 diabetes mellitus	9.08e-05	0.000683	CcSEcCtD
Atropine—Hypotension—Metformin—type 2 diabetes mellitus	9.07e-05	0.000682	CcSEcCtD
Atropine—Erythema—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000681	CcSEcCtD
Atropine—Shock—Irbesartan—type 2 diabetes mellitus	9.01e-05	0.000678	CcSEcCtD
Atropine—Pain—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000677	CcSEcCtD
Atropine—Chest pain—Losartan—type 2 diabetes mellitus	8.99e-05	0.000676	CcSEcCtD
Atropine—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.99e-05	0.000676	CcSEcCtD
Atropine—Anxiety—Losartan—type 2 diabetes mellitus	8.96e-05	0.000674	CcSEcCtD
Atropine—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000672	CcSEcCtD
Atropine—Rash—Bromocriptine—type 2 diabetes mellitus	8.91e-05	0.00067	CcSEcCtD
Atropine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.9e-05	0.000669	CcSEcCtD
Atropine—Tension—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000668	CcSEcCtD
Atropine—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000667	CcSEcCtD
Atropine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000666	CcSEcCtD
Atropine—Headache—Bromocriptine—type 2 diabetes mellitus	8.85e-05	0.000666	CcSEcCtD
Atropine—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.84e-05	0.000665	CcSEcCtD
Atropine—Nervousness—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000661	CcSEcCtD
Atropine—Dry mouth—Losartan—type 2 diabetes mellitus	8.79e-05	0.000661	CcSEcCtD
Atropine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000655	CcSEcCtD
Atropine—Confusional state—Losartan—type 2 diabetes mellitus	8.69e-05	0.000654	CcSEcCtD
Atropine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.68e-05	0.000653	CcSEcCtD
Atropine—Dyspnoea—Metformin—type 2 diabetes mellitus	8.65e-05	0.000651	CcSEcCtD
Atropine—Somnolence—Metformin—type 2 diabetes mellitus	8.63e-05	0.000649	CcSEcCtD
Atropine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.62e-05	0.000648	CcSEcCtD
Atropine—Oedema—Losartan—type 2 diabetes mellitus	8.62e-05	0.000648	CcSEcCtD
Atropine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000648	CcSEcCtD
Atropine—Hypotension—Irbesartan—type 2 diabetes mellitus	8.56e-05	0.000644	CcSEcCtD
Atropine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000643	CcSEcCtD
Atropine—Dyspepsia—Metformin—type 2 diabetes mellitus	8.54e-05	0.000642	CcSEcCtD
Atropine—Shock—Losartan—type 2 diabetes mellitus	8.48e-05	0.000638	CcSEcCtD
Atropine—Urticaria—Valsartan—type 2 diabetes mellitus	8.47e-05	0.000637	CcSEcCtD
Atropine—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.43e-05	0.000634	CcSEcCtD
Atropine—Tachycardia—Losartan—type 2 diabetes mellitus	8.41e-05	0.000633	CcSEcCtD
Atropine—Nausea—Bromocriptine—type 2 diabetes mellitus	8.4e-05	0.000631	CcSEcCtD
Atropine—Fatigue—Metformin—type 2 diabetes mellitus	8.37e-05	0.000629	CcSEcCtD
Atropine—Urticaria—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000629	CcSEcCtD
Atropine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.33e-05	0.000627	CcSEcCtD
Atropine—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.33e-05	0.000626	CcSEcCtD
Atropine—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.33e-05	0.000626	CcSEcCtD
Atropine—Asthenia—Gliclazide—type 2 diabetes mellitus	8.32e-05	0.000626	CcSEcCtD
Atropine—Agitation—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000626	CcSEcCtD
Atropine—Constipation—Metformin—type 2 diabetes mellitus	8.3e-05	0.000624	CcSEcCtD
Atropine—Angioedema—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000622	CcSEcCtD
Atropine—Vomiting—Glyburide—type 2 diabetes mellitus	8.21e-05	0.000618	CcSEcCtD
Atropine—Pruritus—Gliclazide—type 2 diabetes mellitus	8.21e-05	0.000617	CcSEcCtD
Atropine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.000614	CcSEcCtD
Atropine—Rash—Glyburide—type 2 diabetes mellitus	8.15e-05	0.000612	CcSEcCtD
Atropine—Somnolence—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000612	CcSEcCtD
Atropine—Dermatitis—Glyburide—type 2 diabetes mellitus	8.14e-05	0.000612	CcSEcCtD
Atropine—Vertigo—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000612	CcSEcCtD
Atropine—Syncope—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000611	CcSEcCtD
Atropine—Headache—Glyburide—type 2 diabetes mellitus	8.09e-05	0.000609	CcSEcCtD
Atropine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.000606	CcSEcCtD
Atropine—Hypotension—Losartan—type 2 diabetes mellitus	8.06e-05	0.000606	CcSEcCtD
Atropine—Palpitations—Ramipril—type 2 diabetes mellitus	8e-05	0.000602	CcSEcCtD
Atropine—Feeling abnormal—Metformin—type 2 diabetes mellitus	8e-05	0.000601	CcSEcCtD
Atropine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000599	CcSEcCtD
Atropine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.000597	CcSEcCtD
Atropine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.94e-05	0.000597	CcSEcCtD
Atropine—Fatigue—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000594	CcSEcCtD
Atropine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.85e-05	0.00059	CcSEcCtD
Atropine—Convulsion—Ramipril—type 2 diabetes mellitus	7.85e-05	0.00059	CcSEcCtD
Atropine—Pain—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000589	CcSEcCtD
Atropine—Constipation—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000589	CcSEcCtD
Atropine—Insomnia—Losartan—type 2 diabetes mellitus	7.8e-05	0.000586	CcSEcCtD
Atropine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000583	CcSEcCtD
Atropine—Urticaria—Metformin—type 2 diabetes mellitus	7.71e-05	0.00058	CcSEcCtD
Atropine—Chest pain—Ramipril—type 2 diabetes mellitus	7.71e-05	0.00058	CcSEcCtD
Atropine—Dyspnoea—Losartan—type 2 diabetes mellitus	7.69e-05	0.000578	CcSEcCtD
Atropine—Anxiety—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000578	CcSEcCtD
Atropine—Nausea—Glyburide—type 2 diabetes mellitus	7.67e-05	0.000577	CcSEcCtD
Atropine—Abdominal pain—Metformin—type 2 diabetes mellitus	7.67e-05	0.000577	CcSEcCtD
Atropine—Dizziness—Gliclazide—type 2 diabetes mellitus	7.67e-05	0.000577	CcSEcCtD
Atropine—Somnolence—Losartan—type 2 diabetes mellitus	7.66e-05	0.000576	CcSEcCtD
Atropine—Asthenia—Valsartan—type 2 diabetes mellitus	7.65e-05	0.000575	CcSEcCtD
Atropine—Dyspepsia—Losartan—type 2 diabetes mellitus	7.59e-05	0.000571	CcSEcCtD
Atropine—Asthenia—Orlistat—type 2 diabetes mellitus	7.56e-05	0.000568	CcSEcCtD
Atropine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000568	CcSEcCtD
Atropine—Pruritus—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000567	CcSEcCtD
Atropine—Dry mouth—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000567	CcSEcCtD
Atropine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000563	CcSEcCtD
Atropine—Confusional state—Ramipril—type 2 diabetes mellitus	7.45e-05	0.00056	CcSEcCtD
Atropine—Pruritus—Orlistat—type 2 diabetes mellitus	7.45e-05	0.00056	CcSEcCtD
Atropine—Fatigue—Losartan—type 2 diabetes mellitus	7.43e-05	0.000559	CcSEcCtD
Atropine—Oedema—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000556	CcSEcCtD
Atropine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000556	CcSEcCtD
Atropine—Vomiting—Gliclazide—type 2 diabetes mellitus	7.38e-05	0.000555	CcSEcCtD
Atropine—Pain—Losartan—type 2 diabetes mellitus	7.37e-05	0.000554	CcSEcCtD
Atropine—Constipation—Losartan—type 2 diabetes mellitus	7.37e-05	0.000554	CcSEcCtD
Atropine—Rash—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.00055	CcSEcCtD
Atropine—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.31e-05	0.000549	CcSEcCtD
Atropine—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.29e-05	0.000548	CcSEcCtD
Atropine—Urticaria—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000547	CcSEcCtD
Atropine—Shock—Ramipril—type 2 diabetes mellitus	7.27e-05	0.000547	CcSEcCtD
Atropine—Headache—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.000546	CcSEcCtD
Atropine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000544	CcSEcCtD
Atropine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000544	CcSEcCtD
Atropine—Tachycardia—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000542	CcSEcCtD
Atropine—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000542	CcSEcCtD
Atropine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000537	CcSEcCtD
Atropine—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.1e-05	0.000534	CcSEcCtD
Atropine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.05e-05	0.00053	CcSEcCtD
Atropine—Dizziness—Valsartan—type 2 diabetes mellitus	7.05e-05	0.00053	CcSEcCtD
Atropine—Dizziness—Orlistat—type 2 diabetes mellitus	6.96e-05	0.000524	CcSEcCtD
Atropine—Asthenia—Metformin—type 2 diabetes mellitus	6.96e-05	0.000524	CcSEcCtD
Atropine—Hypotension—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000519	CcSEcCtD
Atropine—Nausea—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000518	CcSEcCtD
Atropine—Pruritus—Metformin—type 2 diabetes mellitus	6.87e-05	0.000516	CcSEcCtD
Atropine—Urticaria—Losartan—type 2 diabetes mellitus	6.85e-05	0.000515	CcSEcCtD
Atropine—Abdominal pain—Losartan—type 2 diabetes mellitus	6.81e-05	0.000512	CcSEcCtD
Atropine—Body temperature increased—Losartan—type 2 diabetes mellitus	6.81e-05	0.000512	CcSEcCtD
Atropine—Vomiting—Valsartan—type 2 diabetes mellitus	6.78e-05	0.00051	CcSEcCtD
Atropine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000507	CcSEcCtD
Atropine—Rash—Valsartan—type 2 diabetes mellitus	6.72e-05	0.000505	CcSEcCtD
Atropine—Dermatitis—Valsartan—type 2 diabetes mellitus	6.71e-05	0.000505	CcSEcCtD
Atropine—Vomiting—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000504	CcSEcCtD
Atropine—Insomnia—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000503	CcSEcCtD
Atropine—Headache—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000502	CcSEcCtD
Atropine—Diarrhoea—Metformin—type 2 diabetes mellitus	6.64e-05	0.000499	CcSEcCtD
Atropine—Rash—Orlistat—type 2 diabetes mellitus	6.64e-05	0.000499	CcSEcCtD
Atropine—Dermatitis—Orlistat—type 2 diabetes mellitus	6.63e-05	0.000499	CcSEcCtD
Atropine—Headache—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000496	CcSEcCtD
Atropine—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000495	CcSEcCtD
Atropine—Asthenia—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000494	CcSEcCtD
Atropine—Somnolence—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000494	CcSEcCtD
Atropine—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000489	CcSEcCtD
Atropine—Pruritus—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000487	CcSEcCtD
Atropine—Dizziness—Metformin—type 2 diabetes mellitus	6.42e-05	0.000483	CcSEcCtD
Atropine—Fatigue—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000479	CcSEcCtD
Atropine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.35e-05	0.000478	CcSEcCtD
Atropine—Nausea—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000476	CcSEcCtD
Atropine—Constipation—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000475	CcSEcCtD
Atropine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000471	CcSEcCtD
Atropine—Nausea—Orlistat—type 2 diabetes mellitus	6.26e-05	0.00047	CcSEcCtD
Atropine—Asthenia—Losartan—type 2 diabetes mellitus	6.19e-05	0.000465	CcSEcCtD
Atropine—Vomiting—Metformin—type 2 diabetes mellitus	6.17e-05	0.000464	CcSEcCtD
Atropine—Rash—Metformin—type 2 diabetes mellitus	6.12e-05	0.00046	CcSEcCtD
Atropine—Dermatitis—Metformin—type 2 diabetes mellitus	6.11e-05	0.00046	CcSEcCtD
Atropine—Pruritus—Losartan—type 2 diabetes mellitus	6.1e-05	0.000459	CcSEcCtD
Atropine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000458	CcSEcCtD
Atropine—Headache—Metformin—type 2 diabetes mellitus	6.08e-05	0.000457	CcSEcCtD
Atropine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000455	CcSEcCtD
Atropine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000454	CcSEcCtD
Atropine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.9e-05	0.000443	CcSEcCtD
Atropine—Urticaria—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000442	CcSEcCtD
Atropine—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000439	CcSEcCtD
Atropine—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000439	CcSEcCtD
Atropine—Vomiting—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000438	CcSEcCtD
Atropine—Rash—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000434	CcSEcCtD
Atropine—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.000434	CcSEcCtD
Atropine—Nausea—Metformin—type 2 diabetes mellitus	5.77e-05	0.000433	CcSEcCtD
Atropine—Headache—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000431	CcSEcCtD
Atropine—Dizziness—Losartan—type 2 diabetes mellitus	5.7e-05	0.000429	CcSEcCtD
Atropine—Vomiting—Losartan—type 2 diabetes mellitus	5.48e-05	0.000412	CcSEcCtD
Atropine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000409	CcSEcCtD
Atropine—Nausea—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000409	CcSEcCtD
Atropine—Rash—Losartan—type 2 diabetes mellitus	5.44e-05	0.000409	CcSEcCtD
Atropine—Dermatitis—Losartan—type 2 diabetes mellitus	5.43e-05	0.000408	CcSEcCtD
Atropine—Headache—Losartan—type 2 diabetes mellitus	5.4e-05	0.000406	CcSEcCtD
Atropine—Asthenia—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000399	CcSEcCtD
Atropine—Pruritus—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000393	CcSEcCtD
Atropine—Nausea—Losartan—type 2 diabetes mellitus	5.12e-05	0.000385	CcSEcCtD
Atropine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.06e-05	0.00038	CcSEcCtD
Atropine—Dizziness—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000368	CcSEcCtD
Atropine—Vomiting—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000353	CcSEcCtD
Atropine—Rash—Ramipril—type 2 diabetes mellitus	4.66e-05	0.00035	CcSEcCtD
Atropine—Dermatitis—Ramipril—type 2 diabetes mellitus	4.66e-05	0.00035	CcSEcCtD
Atropine—Headache—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000348	CcSEcCtD
Atropine—Nausea—Ramipril—type 2 diabetes mellitus	4.39e-05	0.00033	CcSEcCtD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.72e-06	0.000113	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.7e-06	0.000113	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.7e-06	0.000113	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.59e-06	0.000111	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	6.56e-06	0.000111	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.51e-06	0.00011	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.51e-06	0.00011	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	6.48e-06	0.000109	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.43e-06	0.000108	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.43e-06	0.000108	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.43e-06	0.000108	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.4e-06	0.000108	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.37e-06	0.000107	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.35e-06	0.000107	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.34e-06	0.000107	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.28e-06	0.000106	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.28e-06	0.000106	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.28e-06	0.000106	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.26e-06	0.000106	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	6.26e-06	0.000106	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.25e-06	0.000105	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.23e-06	0.000105	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.22e-06	0.000105	CbGpPWpGaD
Atropine—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	6.22e-06	0.000105	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.21e-06	0.000105	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.2e-06	0.000104	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.2e-06	0.000104	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.17e-06	0.000104	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.16e-06	0.000104	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.15e-06	0.000104	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—INS—type 2 diabetes mellitus	6.15e-06	0.000104	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.14e-06	0.000104	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.14e-06	0.000104	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	6.1e-06	0.000103	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.08e-06	0.000103	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.07e-06	0.000102	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.06e-06	0.000102	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	6.05e-06	0.000102	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.05e-06	0.000102	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.03e-06	0.000102	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.01e-06	0.000101	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.99e-06	0.000101	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.97e-06	0.000101	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.97e-06	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.95e-06	0.0001	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.95e-06	0.0001	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.95e-06	0.0001	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.92e-06	9.98e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	5.91e-06	9.96e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.9e-06	9.94e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—INS—type 2 diabetes mellitus	5.89e-06	9.93e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.88e-06	9.92e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.88e-06	9.92e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	5.81e-06	9.8e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.8e-06	9.77e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.8e-06	9.77e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	5.79e-06	9.76e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	5.78e-06	9.74e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.77e-06	9.73e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.74e-06	9.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.73e-06	9.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.73e-06	9.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.73e-06	9.67e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	5.72e-06	9.65e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.72e-06	9.64e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.7e-06	9.61e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.7e-06	9.61e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.7e-06	9.6e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.67e-06	9.56e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.67e-06	9.56e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.66e-06	9.53e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.65e-06	9.53e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.6e-06	9.44e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.6e-06	9.43e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.53e-06	9.33e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.44e-06	9.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.42e-06	9.14e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.41e-06	9.12e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.4e-06	9.1e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.4e-06	9.1e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.37e-06	9.05e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.34e-06	9e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.32e-06	8.97e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.27e-06	8.88e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	5.22e-06	8.79e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	5.2e-06	8.77e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.17e-06	8.71e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.17e-06	8.71e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.16e-06	8.69e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	5.15e-06	8.68e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.14e-06	8.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.14e-06	8.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.14e-06	8.67e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	5.08e-06	8.56e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.05e-06	8.51e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	5.04e-06	8.5e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5e-06	8.43e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.98e-06	8.39e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.96e-06	8.37e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.96e-06	8.36e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.96e-06	8.36e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.95e-06	8.34e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	4.95e-06	8.34e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	4.94e-06	8.33e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.93e-06	8.32e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.91e-06	8.28e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.9e-06	8.26e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.9e-06	8.25e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.89e-06	8.25e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.88e-06	8.22e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	4.87e-06	8.2e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.86e-06	8.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.86e-06	8.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.86e-06	8.19e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	4.84e-06	8.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	4.84e-06	8.16e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.81e-06	8.11e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.8e-06	8.09e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.8e-06	8.08e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.8e-06	8.08e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.79e-06	8.07e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.74e-06	7.99e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.7e-06	7.93e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.65e-06	7.84e-05	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.63e-06	7.8e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.58e-06	7.72e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.58e-06	7.72e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.57e-06	7.7e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.55e-06	7.67e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.54e-06	7.65e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	4.54e-06	7.64e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.52e-06	7.62e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.51e-06	7.61e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.46e-06	7.52e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.46e-06	7.52e-05	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.43e-06	7.47e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.39e-06	7.4e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.36e-06	7.35e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	4.34e-06	7.31e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.34e-06	7.31e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.33e-06	7.3e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.33e-06	7.3e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.32e-06	7.28e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.28e-06	7.22e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.28e-06	7.21e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.2e-06	7.08e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	4.15e-06	6.99e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.15e-06	6.99e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	4.14e-06	6.97e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.1e-06	6.92e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	4.1e-06	6.9e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.08e-06	6.88e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.07e-06	6.86e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.03e-06	6.79e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.02e-06	6.78e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.01e-06	6.77e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.01e-06	6.76e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4e-06	6.74e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4e-06	6.74e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.99e-06	6.73e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	3.99e-06	6.73e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.98e-06	6.71e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	3.97e-06	6.69e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.96e-06	6.68e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.96e-06	6.67e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.94e-06	6.65e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.89e-06	6.55e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.84e-06	6.48e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.84e-06	6.48e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.83e-06	6.45e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	3.82e-06	6.44e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.81e-06	6.42e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.8e-06	6.4e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.78e-06	6.36e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.76e-06	6.34e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.72e-06	6.28e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.67e-06	6.18e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.64e-06	6.13e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.64e-06	6.13e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.63e-06	6.11e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.63e-06	6.11e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.59e-06	6.06e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.59e-06	6.06e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.57e-06	6.02e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.57e-06	6.01e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.5e-06	5.9e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.5e-06	5.9e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.43e-06	5.77e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.43e-06	5.77e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.42e-06	5.76e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.41e-06	5.76e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.41e-06	5.75e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.38e-06	5.7e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.35e-06	5.65e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.33e-06	5.6e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.28e-06	5.53e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.15e-06	5.31e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.12e-06	5.26e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.11e-06	5.24e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.09e-06	5.21e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.09e-06	5.21e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.08e-06	5.19e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.08e-06	5.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.07e-06	5.17e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.06e-06	5.16e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.05e-06	5.14e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.03e-06	5.11e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.99e-06	5.05e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.94e-06	4.96e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.93e-06	4.94e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.92e-06	4.92e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.91e-06	4.91e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.9e-06	4.89e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.89e-06	4.87e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.88e-06	4.86e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.88e-06	4.85e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.85e-06	4.81e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.83e-06	4.77e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.82e-06	4.76e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.8e-06	4.71e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.69e-06	4.54e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	2.69e-06	4.53e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.68e-06	4.52e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.66e-06	4.48e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.62e-06	4.42e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.61e-06	4.41e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.59e-06	4.36e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	2.58e-06	4.34e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.56e-06	4.31e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	4.22e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.48e-06	4.18e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.41e-06	4.06e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.4e-06	4.04e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.38e-06	4e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.38e-06	4e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.36e-06	3.98e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.35e-06	3.96e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.33e-06	3.93e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.3e-06	3.87e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.2e-06	3.7e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.2e-06	3.7e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	3.39e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.99e-06	3.36e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	3.06e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	3.05e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.79e-06	3.02e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	2.82e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	2.81e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.65e-06	2.78e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.7e-05	CbGpPWpGaD
